We are live on ! Find out more
CCXI

ChemoCentryx, Inc.
CCXI

Delisted

CCXI was delisted on the 19th of October, 2022.

Back to rankings

86 hedge funds and large institutions have $177M invested in ChemoCentryx, Inc. in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 24 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 24

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less funds holding

Funds holding: 88 → 86 (-2)

14% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 14

23% less capital invested

Capital invested by funds: $228M → $177M (-$51.5M)

Holders
86
Holders Change
-2
Holders Change %
-2.27%
% of All Funds
2.14%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
31
Reduced
24
Closed
14
Calls
$201K
Puts
–
Net Calls
+$201K
Net Calls Change
+$304K

Top Buyers

1
BlackRock
BlackRock
New York
+$3.69M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.69M
3
Goldman Sachs
Goldman Sachs
New York
+$1.22M
4
Millennium Management
Millennium Management
New York
+$814K
5
ZIM
Zacks Investment Management
Illinois
+$660K

Top Sellers

1
BI
BVF Inc
California
-$5.49M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$3.23M
3
SCM
Sio Capital Management
New York
-$1.83M
4
EC
EcoR1 Capital
California
-$1.1M
5
AllianceBernstein
AllianceBernstein
Tennessee
-$1.02M
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
76
Royal Bank of Canada
Ontario, Canada
$16K +$17.7K +2,132 New
AIP
77
Ameritas Investment Partners
Nebraska
$14K – – –
GWM
78
Geneos Wealth Management
Colorado
$14K – – –
Citigroup
79
Citigroup
New York
$14K +$14K +1,682 +1,045%
Barclays
80
Barclays
United Kingdom
$13K -$14.7K -1,771 -50%
UBS Group
81
UBS Group
Switzerland
$5K +$5.15K +619 New
PCM
82
Prelude Capital Management
New York
$4K -$9.14K -1,100 -69%
Simplex Trading
83
Simplex Trading
Illinois
$3K +$2.59K +312 +284%
CG
84
Cutler Group
California
$3K +$2.91K +350 +427%
FDCDDQ
85
Federation des caisses Desjardins du Quebec
Quebec, Canada
$2.9K – – –
MAM
86
Meeder Asset Management
Ohio
$1K – – –
EC
87
EcoR1 Capital
California
– -$1.1M -118,000 Closed
BIM
88
Bogle Investment Management
Massachusetts
– -$888K -94,897 Closed
Thrivent Financial for Lutherans
89
Thrivent Financial for Lutherans
Minnesota
– -$625K -66,747 Closed
TC
90
TFS Capital
Pennsylvania
– -$614K -65,553 Closed
EGA
91
Eagle Global Advisors
Texas
– -$586K -62,640 Closed
WCM
92
Wedge Capital Management
North Carolina
– -$424K -45,300 Closed
CEP
93
Chicago Equity Partners
Illinois
– -$273K -29,200 Closed
TI
94
Trexquant Investment
Connecticut
– -$174K -18,600 Closed
JP Morgan Chase
95
JP Morgan Chase
New York
– -$104K -11,097 Closed
Creative Planning
96
Creative Planning
Kansas
– -$70K -7,500 Closed
Walleye Trading
97
Walleye Trading
New York
– -$55 -5,900 Closed
AIM
98
Acrospire Investment Management
Illinois
– -$42K -4,504 Closed
AG
99
Advisor Group
Arizona
– -$14K -1,500 Closed
TDC
100
Thompson Davis & Co
Virginia
– -$5K -500 Closed
1 2 3
4

CCXI Hedge Fund Activity: Q3 2017 in Review

86 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q3 2017, worth a combined $177M — down 23% from $228M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of CCXI and 12 opened new positions — a net loss of 2 holders — while 24 trimmed existing stakes and 31 added.

The largest buyer was BlackRock, adding an estimated $3.69M. The largest seller was BVF Inc, cutting an estimated $5.49M.

  • 86 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q3 2017, down from 88 in Q2 2017.
  • Funds reported $177M of ChemoCentryx, Inc. stock for Q3 2017, down 23% quarter-over-quarter.
  • 12 funds opened new ChemoCentryx, Inc. positions in Q3 2017 and 14 closed out, a net change of -2 holders.
  • The largest ChemoCentryx, Inc. buyer in Q3 2017 was BlackRock, an estimated $3.69M added.
  • The largest ChemoCentryx, Inc. seller in Q3 2017 was BVF Inc, an estimated $5.49M sold.

Based on aggregated 13F filings for Q3 2017.